EcoDrugPlus

Methionyl Aminopeptidase 2

Ensembl ID : ENSSFOG00015021604
Gene Symbol: METAP2
3 Cross references
220 Possible Orthologues:

Microtubule-Associated Protein Tau-Like

Ensembl ID : ENSSFOG00015020878
Gene Symbol: LOC108941580
2 Cross references
244 Possible Orthologues:

Mineralocorticoid Receptor

Ensembl ID : ENSSFOG00015016030
Gene Symbol: LOC108924478
3 Cross references
210 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSSFOG00015030447
Gene Symbol: MAPK1
1 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSSFOG00015027966
Gene Symbol: LOC108933025
3 Cross references
152 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSSFOG00015022045
Gene Symbol: MAPK10
3 Cross references
21 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSSFOG00015013508
Gene Symbol: MAPK11
3 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSSFOG00015023518
Gene Symbol: MAPK14
3 Cross references
223 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSSFOG00015027162
Gene Symbol: MAPK3
3 Cross references
173 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSSFOG00015008818
Gene Symbol: LOC108918907
3 Cross references
221 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSSFOG00015016648
Gene Symbol: MAPK8
3 Cross references
225 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSSFOG00015022465
Gene Symbol: MAPK9
1 Cross references
148 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).